Robeco Institutional Asset Management B.V. Has $56.50 Million Holdings in Humana Inc. $HUM

Robeco Institutional Asset Management B.V. grew its position in shares of Humana Inc. (NYSE:HUM) by 23.9% in the 3rd quarter, Holdings Channel reports. The firm owned 217,170 shares of the insurance provider’s stock after acquiring an additional 41,962 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Humana were worth $56,501,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Elevation Point Wealth Partners LLC acquired a new position in Humana in the second quarter valued at $32,000. Mather Group LLC. bought a new position in shares of Humana in the 3rd quarter worth about $34,000. Private Wealth Management Group LLC raised its position in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares in the last quarter. AlphaCore Capital LLC acquired a new position in shares of Humana in the 2nd quarter valued at about $39,000. Finally, SJS Investment Consulting Inc. boosted its position in shares of Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 193 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of HUM opened at $275.14 on Thursday. The firm has a market capitalization of $33.09 billion, a P/E ratio of 25.79, a P/E/G ratio of 2.30 and a beta of 0.45. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock has a 50 day moving average price of $254.49 and a two-hundred day moving average price of $261.91. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.16 earnings per share. Equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on HUM shares. Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and raised their target price for the stock from $253.00 to $313.00 in a research note on Friday, December 5th. KeyCorp reiterated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Bank of America raised their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Guggenheim reiterated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $292.05.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.